Zinc Supplement has emerged as a primary element of choice for managing Covid-19 symptoms along with anti-infective and other anti-parasite drug, according to Dr. Scott Read, Senior Lecturer, School of Medicine at Western Sydney University, Australia.
Dr Scott recommends prophylactic use of zinc may be in a lower dose of 20 mg improves systemic zinc levels but higher dosage is required in acute infections. “Zinc deficiency has been associated with increased susceptibility to infectious disease including viral infection.” Dr. Scott said.
Study has shown that zinc rating of an individual is a critical factor that influence immunity against viral infections.
He further added that Zinc promises to be a candidate to reduce the severity of Covid-19 infection. Several published observation have raised global enthusiasm that zinc therapy could be a possible therapeutic option. The biggest challenge in realizing the therapeutic value of zinc is lack of understanding of optimal dosage of zinc supplementation.
The right amount of zinc, that is 50 mg is available in few brands would allow it achieve its therapeutic potential against Covid-19 but could bypass the baffle associated with multiple responses and efficacies related with insufficient dosage intake of zinc, offered by majority of conventional brands available in the market.
In India, few brands are available with 50 mg dose strength such as Zincolife, Aarzin etc. 50 mg zinc with its unbeaten role as a detail therapy for Covid-19 and advantages as lack of toxicity, low cost and ease of availability could be rapidly implemented clinically.
Even in view of second wave, governments of Uttar Pradesh, West Bengal, Maharastra and Assam have already included zinc along with other nutraceuticals, anti-infectives, corticosteroids & antiparasitic, etc. drugs in their protocol for the management of Covid.